Major Shareholders

Summary of Issued Securities 

Ordinary Shares

 
Issued Shares at 31 March 2017 319,106,844
Employee options over ordinary shares at 31 March 2017 10,325,250

Major Shareholders 
The top 20 Shareholders in Pharmaxis Ltd on 31 March 2017 are:

Name Number Of Shares % Total 
1. Citicorp Nominees Pty Limited 97,533,219 30.6%
2. National Nominees Limited 32,037,438 10.0%
3. HSBC Custody Nomiees (Australia) Limited  24,202,457  7.6%
4. JP Morgan Nominees Australia Limited 15,147,753 4.8%
5. George Engineering Pty Ltd (PG Super Fund) 2,500,000 0.8%
6. Healthcare Management Consulting (Australia) Pty Ltd 2,220,000 0.7%
7. Mutual Trust Pty Ltd 2,185,000 0.7%
8. Pakasoluto Pty Limited (Barkl Family Super Fund A/C) 2,086,838 0.7%
9. Mr Yingkai Li 1,818,290 0.6%
10. Simgon Pty Ltd 1,750,000 0.6%
11. Moggs Creek Pty Ltd (Moggs Creek Super A/C) 1,747,020 0.6%
12. Alpha Matilda Trading Pty Ltd 1,579,245 0.5%
13. David Newnham Super Pty Ltd 1,500,000 0.5%
14. Lawn Views Pty Ltd 1,252,980 0.4%
15. Mr Marco Andrea Negro  1,200,000 0.4% 
16. Ginga Pty Ltd (TG Klinger S/F a/c) 1,159,397 0.4%
17. Mr Brian Tully & Mrs Margaret Tully 1,145,500 0.4%
18. Killcare Holdings Pty Ltd 1,104,413 0.4%
19. Capital Regional et Cooperatif Desjardins 1,053,867 0.3%
20. Ms Bei Xu + Mr Dongning Wu 1,008,747 0.3%

Note: the above tables are updated after each quarter end

Substantial Shareholders 
Pharmaxis has received the following substantial shareholder notices: 

Name Percent Date 
BVF Partners LP 18.94% 4 April 2017
Australian Ethical Australian Share Fund 10.16% 3 April 2017
Allan Gray Australia 8.16% 5 April 2017
Montoya Investments Limited 6.20% 12 April 2013